Total income stood at Rs 396 crore for the June quarter against Rs 303 crore in the year-ago period, AstraZeneca Pharma India said in a regulatory filing
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Total income stood at Rs 396 crore for the June quarter against Rs 303 crore in the year-ago period, AstraZeneca Pharma India said in a regulatory filing
| Subscribe To Our Free Newsletter |
